Durability of XBB.1.5 Vaccines against Omicron Subvariants

A data survey of 1.8 million people in Nebraska showed that XBB.1.5 vaccine effectiveness was 52% against infection and 67% against hospitalization, despite a decline in circulating XBB.1.5 during data collection.

​   The New England Journal of Medicine: Search Results in Infectious Disease